Lista de obras - Maria M Santoro - Dominio Público Uruguay

'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing

artículo científico publicado en 2011

A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART

artículo científico publicado en 2014

Alarming rates of virological failure and HIV‐1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY‐study in Cameroon

artículo científico publicado en 2021

Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors

artículo científico publicado en 2007

Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon

artículo científico publicado en 2012

Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria

artículo científico publicado en 2008

Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based study

artículo científico publicado en 2013

Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains

artículo científico publicado en 2017

Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy

artículo científico publicado en 2012

Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens

artículo científico publicado en 2010

Docking analysis and resistance evaluation of clinically relevant mutations associated with the HIV-1 non-nucleoside reverse transcriptase inhibitors nevirapine, efavirenz and etravirine

artículo científico publicado en 2011

Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon

artículo científico publicado en 2011

Genetic diversity of HIV type 1 in Montenegro

artículo científico publicado en 2010

Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level Viremia

artículo científico publicado en 2015

Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA.

artículo científico

HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Crosssectional Design

article

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia

artículo científico publicado en 2015

High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians.

artículo científico publicado en 2015

High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations

artículo científico publicado en 2005

Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy

artículo científico publicado en 2015

Impact of pre-therapy viral load on virological response to modern first-line HAART.

artículo científico

Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen

artículo científico publicado en 2016

Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score

artículo científico publicado en 2010

Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score

artículo científico publicado en 2011

Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors

artículo científico publicado en 2006

Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test

artículo científico publicado en 2010

Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy

artículo científico publicado en 2014

Molecular epidemiology of HIV type 1 CRF02_AG in Cameroon and African patients living in Italy

artículo científico publicado en 2011

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

artículo científico publicado en 2017

Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children

artículo científico publicado en 2018

Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy.

artículo científico publicado en 2009

Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors

artículo científico publicado en 2005

Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon.

artículo científico publicado en 2011

Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, Italy

artículo científico publicado en 2010

Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen

artículo científico publicado en 2016

Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy

artículo científico publicado en 2015

Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels

artículo científico publicado en 2014

Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines

artículo científico publicado en 2015

Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure

artículo científico publicado en 2008

Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection

artículo científico publicado en 2014

Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen

artículo científico publicado en 2013

Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach

artículo científico publicado en 2022

The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries

artículo científico publicado en 2008

The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro

artículo científico publicado en 2016

The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing

artículo científico publicado en 2013

The multifactorial pathways towards resistance to the cytosine analogues emtricitabine and lamivudine: evidences from literature

artículo científico publicado en 2014

Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients.

artículo científico publicado en 2009

Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir

artículo científico publicado en 2010

Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study

artículo científico publicado en 2008

Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.

artículo científico publicado en 2016

Lista de obras de Maria M Santoro

'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing

A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART

Alarming rates of virological failure and HIV‐1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY‐study in Cameroon

Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors

Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon

Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria

Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based study

Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains

Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy

Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens

Docking analysis and resistance evaluation of clinically relevant mutations associated with the HIV-1 non-nucleoside reverse transcriptase inhibitors nevirapine, efavirenz and etravirine

Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon

Genetic diversity of HIV type 1 in Montenegro

Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level Viremia

Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA.

HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Crosssectional Design

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia

High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians.

High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations

Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy

Impact of pre-therapy viral load on virological response to modern first-line HAART.

Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen

Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score

Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score

Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors

Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test

Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy

Molecular epidemiology of HIV type 1 CRF02_AG in Cameroon and African patients living in Italy

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children

Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy.

Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors

Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon.

Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, Italy

Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen

Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy

Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels

Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines

Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure

Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection

Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen

Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach

The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries

The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro

The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing

The multifactorial pathways towards resistance to the cytosine analogues emtricitabine and lamivudine: evidences from literature

Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients.

Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir

Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study

Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.